TISOTUMAB VEDOTIN (TV) plus BEVACIZUMAB OR PEMBROLIZUMAB OR CARBOPLATIN IN RECURRENT/METASTATIC CERVICAL CANCER (R/MCC): PHASE 1B/2 ENGOT-CX8/GOG-3024/INNOVATV 205 STUDY DOSE-ESCALATION RESULTS

被引:3
作者
Monk, B. [1 ]
Van Gorp, T. [2 ]
Lorusso, D. [3 ]
O'Cearbhaill, R. Eilish [4 ]
Westermann, A. [5 ]
Banerjee, S. [6 ]
Collins, D. [7 ]
Klat, J. [8 ]
Madsen, K. [9 ]
Baurain, J-F [10 ]
Jackson, A. [11 ]
Boere, I. [12 ]
Pignata, S. [13 ]
Gort, E. [14 ]
Moroney, J. [15 ]
Soumaoro, I. [16 ]
Andreassen, Cm [17 ]
Nicacio, L. [18 ]
Gennigens, C. [19 ]
Vergote, I. [20 ]
机构
[1] Creighton Univ, Univ Arizona, Arizona Oncol US Oncol Network, Div Gynecol Oncol, Phoenix, AZ USA
[2] Katholieke Univ Leuven, Univ Hosp Leuven, Gynecol Oncol, Leuven, Belgium
[3] Fdn Policlin Univ Agostino Gemelli IRCCS, Div Gynecol Oncol, Rome, Italy
[4] Mem Sloan Kettering Canc Ctr, Med, 1275 York Ave, New York, NY 10021 USA
[5] Acad Med Ctr, Dept Med Oncol, Amsterdam, Netherlands
[6] Royal Marsden NHS Fdn Trust, Med Oncol, London, England
[7] Cork Univ Hosp, Oncol Trials Unit, Cork, Ireland
[8] Univ Hosp Ostrava, Gynecol Oncol, Ostrava, Czech Republic
[9] Univ Hosp Copenhagen, Rigshosp, Med Oncol, Copenhagen, Denmark
[10] Univ Catholique Louvain UCLouvain, Med Oncol, Brussels, Belgium
[11] Univ Cincinnati, Canc Ctr, Gynecol Oncol, Cincinnati, OH USA
[12] Erasmus MC, Canc Inst, Med Oncol, Rotterdam, Netherlands
[13] Inst Nazl Tumori IRCCS Fdn G Pascale, Med Oncol, Naples, Italy
[14] Univ Med Ctr Utrecht, Med Oncol, Utrecht, Netherlands
[15] Univ Chicago, Obstet & Gynecol, Chicago, IL 60637 USA
[16] Genmab US Inc, Med Oncol, Princeton, NJ USA
[17] Genmab, Biostat, Copenhagen, Denmark
[18] Seagen Inc, Med Oncol, Bothell, WA USA
[19] Ctr Hosp Univ Liege, Med Oncol, Liege, Belgium
[20] Univ Leuven, Leuven Canc Inst, Belgium & Luxembourg Gynaecol Oncol Grp, Leuven, Belgium
关键词
D O I
10.1136/ijgc-2021-IGCS.13
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
O013/#573
引用
收藏
页码:A7 / A8
页数:2
相关论文
empty
未找到相关数据